Monitoring of post‐transplant CBFB‐MYH11 as minimal residual disease, rather than KIT mutations, can predict relapse after allogeneic haematopoietic cell transplantation in adults with inv(16) acute myeloid leukaemia

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 3, 2018-02 ,pp. : 448-451

John Wiley & Sons Inc

Access to resources Recommend Favorite

Superiority of preemptive donor lymphocyte infusion based on minimal residual disease in acute leukemia patients after allogeneic hematopoietic stem cell transplantation

By  

TRANSFUSION, Vol. 54, Iss. 6, 2014-06 ,pp. : 1493-1500

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Implications of Minimal Residual Disease Monitoring for Stem Cell Transplantation after Reduced Intensity and Nonmyeloablative Conditioning

By  

Acta Haematologica, Vol. 112, Iss. 1-2, 2004-06 ,pp. : 93-104

Karger

Access to resources Recommend Favorite

Allogeneic haematopoietic stem cell transplantation for infant acute lymphoblastic leukaemia with KMT2A (MLL) rearrangements: a retrospective study from the paediatric acute lymphoblastic leukaemia working group of the Japan Society for Haematopoietic Cell Transplantation

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 4, 2015-02 ,pp. : 564-570

John Wiley & Sons Inc

Access to resources Recommend Favorite

The clinical impact of IKZF1 deletions in paediatric B‐cell precursor acute lymphoblastic leukaemia is independent of minimal residual disease stratification in Nordic Society for Paediatric Haematology and Oncology treatment protocols used between 1992 and 2013

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 6, 2015-09 ,pp. : 847-858

John Wiley & Sons Inc

Access to resources Recommend Favorite